News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Bud-wiser: DOD Backs A-Alpha Bio for Biothreat Preparation
A-Alpha Bio, a Seattle-based biotechnology company, announced the Department of Defense has awarded the company another $14.5 million to accelerate its antibody discovery and optimize
US FDA approves expanded use of Bristol Myers’ cancer cell therapy
Bristol Myers Squibb received expanded FDA approval for cancer cell therapy Breyanzi, to treat adults with a type of blood cancer called follicular lymphoma that
$400,000 awarded to Seattle ovarian cancer researchers
This week, funds began flowing to local cancer research institutions as part of a $1 million grant towards ovarian cancer research in the state, awarded
A meeting of the mayors: Spokane’s Lisa Brown and Seattle’s Bruce Harrell on the impact of innovation
Recently, Seattle Mayor Bruce Harrell and Spokane Mayor Lisa Brown met for a fireside chat at a Technology Alliance event. During the event, the mayors
Pfizer, Genmab’s ADC Tivdak Scores Full FDA Approval in Recurrent or Metastatic Cervical Cancer
The FDA has granted full approval to Pfizer and Genmab’s antibody-drug conjugate Tivdak for the treatment of recurrent or metastatic cervical cancer that had progressed on or after chemotherapy. Chris
Seattle is the nation’s second-biggest new AI job hotspot
A recent analysis identifies Seattle, San Francisco, and San Jose as the top three new AI job hotspots in the United States. Seattle ranks second
Washington Innovation Network Mentoring Program Marks 10 Years Helping Life-Science Companies
Sahil Diwan, CEO and co-founder of SafKan Health, a Redmond-based company, underscores the invaluable role of mentorship provided by Life Science Washington Institute’s WIN Mentoring
Report: Life Sciences Industry Economic Impact Approaches $40B in Washington
Life Science Washington released its annual Economic Impact Report and Washington State Investor Report, showing the industry’s strong growth over the last couple of years.
AI is boosting drug discovery and development — and sparking questions about proprietary data
In a panel discussion at Life Science Washington’s annual conference, Life Science Innovation Northwest, Danielle Greenawalt (Scientific Executive Director of Translational Informatics and Predictive Sciences,
New study for early detection of Alzheimer’s shows promising results
Seattle biotech startup AltPep and researchers at the University of Washington announced promising results from a new study on the early detection of Alzheimer’s Disease.
Seattle biotech research hub launches with big goals for growth, scientific advances
The Seattle Hub for Synthetic Biology, a joint initiative of the Allen Institute, the University of Washington and the Chan Zuckerberg Initiative, celebrated its official
Vertex will buy Alpine Immune Sciences for $4.9B in another big Seattle biotech deal
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $4.9 billion. Alpine develops immunotherapies to address cancer, kidney disease, and other serious autoimmune and inflammatory